| Miss Amanda Jane Warner, DPM | |
|
103 Summit Centre Dr, Columbia, SC 29229-7613 | |
| (803) 356-4712 | |
| (803) 356-0832 |
| Full Name | Miss Amanda Jane Warner |
|---|---|
| Gender | Female |
| Speciality | Podiatry |
| Experience | 11 Years |
| Location | 103 Summit Centre Dr, Columbia, South Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326570524 | NPI | - | NPPES |
| PD6835 | Medicaid | SC |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lexington Medical Center | West columbia, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lexington Health Inc | 2567872070 | 753 |
News Archive
Since 2005, the guidelines for the care of unconscious cardiac arrest patients have been to cool the body temperature down to 33 degrees Celsius. A large, randomized clinical trial led by Lund University and Region Skåne in Sweden has shown that this treatment does not improve survival. The study is published in the New England Journal of Medicine.
Kansas Venture Capital, Inc. (KVCI) has acquired the former AAIPharma bioanalytical division from ZeeCRO Inc. With its 30-year track record of developing entrepreneurial companies, KVCI will grow the bioanalytical business through organic and acquisition strategies to provide best-in-class analytical services for both the pharmaceutical and life sciences sectors.
Synthetic Biologics, Inc., a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, and Enterome Bioscience SA, a pioneer in the development of innovative disease management solutions based on a deep understanding of the gut microbiome, today announced that they have entered into an agreement to conduct metagenomic research on the effects of beta-lactam antibiotics on the gastrointestinal microflora (microbiome) of human patients.
We think of asthma and other allergic diseases as unnecessary aberrant immune responses that do more harm than good. However, new evidence by an international team led by researchers at Baylor College of Medicine shows that some allergic reactions provide necessary protection against highly invasive and potentially lethal infectious agents, such as yeast.
The emerging threat of pesticide resistance means that biological malaria control methods are once again in vogue.
› Verified 1 days ago
| Provider Name | Lexington Health Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1710634753 PECOS PAC ID: 2567872070 Enrollment ID: O20201208000922 |
News Archive
Since 2005, the guidelines for the care of unconscious cardiac arrest patients have been to cool the body temperature down to 33 degrees Celsius. A large, randomized clinical trial led by Lund University and Region Skåne in Sweden has shown that this treatment does not improve survival. The study is published in the New England Journal of Medicine.
Kansas Venture Capital, Inc. (KVCI) has acquired the former AAIPharma bioanalytical division from ZeeCRO Inc. With its 30-year track record of developing entrepreneurial companies, KVCI will grow the bioanalytical business through organic and acquisition strategies to provide best-in-class analytical services for both the pharmaceutical and life sciences sectors.
Synthetic Biologics, Inc., a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, and Enterome Bioscience SA, a pioneer in the development of innovative disease management solutions based on a deep understanding of the gut microbiome, today announced that they have entered into an agreement to conduct metagenomic research on the effects of beta-lactam antibiotics on the gastrointestinal microflora (microbiome) of human patients.
We think of asthma and other allergic diseases as unnecessary aberrant immune responses that do more harm than good. However, new evidence by an international team led by researchers at Baylor College of Medicine shows that some allergic reactions provide necessary protection against highly invasive and potentially lethal infectious agents, such as yeast.
The emerging threat of pesticide resistance means that biological malaria control methods are once again in vogue.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Miss Amanda Jane Warner, DPM Po Box 6069, West Columbia, SC 29171-6069 Ph: () - | Miss Amanda Jane Warner, DPM 103 Summit Centre Dr, Columbia, SC 29229-7613 Ph: (803) 356-4712 |
News Archive
Since 2005, the guidelines for the care of unconscious cardiac arrest patients have been to cool the body temperature down to 33 degrees Celsius. A large, randomized clinical trial led by Lund University and Region Skåne in Sweden has shown that this treatment does not improve survival. The study is published in the New England Journal of Medicine.
Kansas Venture Capital, Inc. (KVCI) has acquired the former AAIPharma bioanalytical division from ZeeCRO Inc. With its 30-year track record of developing entrepreneurial companies, KVCI will grow the bioanalytical business through organic and acquisition strategies to provide best-in-class analytical services for both the pharmaceutical and life sciences sectors.
Synthetic Biologics, Inc., a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, and Enterome Bioscience SA, a pioneer in the development of innovative disease management solutions based on a deep understanding of the gut microbiome, today announced that they have entered into an agreement to conduct metagenomic research on the effects of beta-lactam antibiotics on the gastrointestinal microflora (microbiome) of human patients.
We think of asthma and other allergic diseases as unnecessary aberrant immune responses that do more harm than good. However, new evidence by an international team led by researchers at Baylor College of Medicine shows that some allergic reactions provide necessary protection against highly invasive and potentially lethal infectious agents, such as yeast.
The emerging threat of pesticide resistance means that biological malaria control methods are once again in vogue.
› Verified 1 days ago
Dr. Maureen Quinlan, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1730 Saint Julian Pl, Columbia, SC 29204 Phone: 803-256-6776 Fax: 803-256-6778 | |
Elgin Podiatry Institute, Llc Podiatrist Medicare: Medicare Enrolled Practice Location: 3 Richland Medical Park Dr, Suite 110, Columbia, SC 29203 Phone: 803-807-9388 Fax: 803-807-9391 | |
Dr. Carly Chapman, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1516 Calhoun St, Columbia, SC 29201 Phone: 803-254-6114 Fax: 803-254-7674 | |
James A Suber, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 1516 Calhoun St, Columbia, SC 29201 Phone: 803-254-6114 Fax: 803-254-7674 | |
Carolina Family Podiatry,llc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 131 Wildewood Park Dr, Columbia, SC 29223 Phone: 803-462-7040 Fax: 803-462-7047 | |
Thomas A F Pinner, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 2200 Harden St, Columbia, SC 29203 Phone: 803-898-8405 Fax: 808-898-8526 | |
Prisma Health Medical Group-midlands Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 3 Richland Medical Park Dr Ste 350, Columbia, SC 29203 Phone: 803-434-6838 Fax: 803-434-6878 |